Literature DB >> 7401098

Synthesis of 1,3-diazepin-2-one nucleosides as transition-state inhibitors of cytidine deaminase.

V E Marquez, P S Liu, J A Kelley, J S Driscoll, J J McCormack.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7401098     DOI: 10.1021/jm00181a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

1.  Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.

Authors:  J Laliberté; V E Marquez; R L Momparler
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.

Authors:  Madhavi Billam; Michele D Sobolewski; Nancy E Davidson
Journal:  Breast Cancer Res Treat       Date:  2009-05-21       Impact factor: 4.872

3.  Synthesis of conformationally locked carbocyclic 1,3-diazepinone nucleosides as inhibitors of cytidine deaminase.

Authors:  Olaf R Ludek; Gottfried K Schroeder; Richard Wolfenden; Victor E Marquez
Journal:  Nucleic Acids Symp Ser (Oxf)       Date:  2008

4.  DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.

Authors:  Dana M van Bemmel; Adam S Brank; Ramon Eritja; Victor E Marquez; Judith K Christman
Journal:  Biochem Pharmacol       Date:  2009-05-23       Impact factor: 5.858

5.  Cytidine deaminase can deaminate fused pyrimidine ribonucleosides.

Authors:  Paul T Ludford; Yao Li; Shenghua Yang; Yitzhak Tor
Journal:  Org Biomol Chem       Date:  2021-07-21       Impact factor: 3.890

6.  Zebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells.

Authors:  Kazuaki Nakamura; Kazuko Aizawa; Kyaw Htet Aung; Junji Yamauchi; Akito Tanoue
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.